Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Tenon Medical, Inc. ( (TNON) ) is now available.
On October 13, 2025, Tenon Medical, Inc. issued 866,642 restricted stock units (RSUs) to its directors and officers under its 2022 Equity Incentive Plan. These RSUs will vest in two installments, with 50% converting into common stock on January 1, 2026, and the remaining 50% on July 31, 2026, utilizing an exemption from the Securities Act of 1933.
The most recent analyst rating on (TNON) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Tenon Medical, Inc. stock, see the TNON Stock Forecast page.
Spark’s Take on TNON Stock
According to Spark, TipRanks’ AI Analyst, TNON is a Neutral.
Tenon Medical, Inc. faces challenges with profitability and valuation, impacting its overall score. While strategic initiatives and financial discipline are promising, the company’s reliance on external funding and negative cash flows are significant concerns. Technical indicators suggest potential stability, but bearish momentum persists.
To see Spark’s full report on TNON stock, click here.
More about Tenon Medical, Inc.
Average Trading Volume: 4,437,222
Technical Sentiment Signal: Sell
Current Market Cap: $10.92M
For detailed information about TNON stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- RTO Doesn’t Always Mean RTO: Microsoft Stock (NASDAQ:MSFT) Notches Up as Salespeople Find Exemption
- This Was Not the First Bid: Warner Bros. Discovery Stock (NASDAQ:WBD) Gains as it Rejected Three Bids from Paramount So Far
- ‘Paramount Can Walk Away with Warner Bros.’ Say TD Cowen and Benchmark Analysts